Box News

Prednisolone is a steroid medicine called a corticosteroid. It is different from the “muscle-building” type of steroids that people sometimes talk about. Prednisolone works by reducing inflammation and calming an overactive immune response. Because of that, it is used for many health problems, including asthma, arthritis, autoimmune diseases such as lupus, skin conditions such as eczema and rashes, and some kinds of cancer. (MedlinePlus)

The main health benefit of prednisolone is that it can quickly ease swelling, redness, and irritation. It can also help stop symptoms from getting worse or help prevent a problem from happening in the first place. In eye treatment, prednisolone can reduce redness, burning, and swelling from eye inflammation, and it is sometimes used after eye surgery. (nhs.uk)

For many people, that means faster relief from flare-ups that make daily life harder. When inflammation is driving symptoms, prednisolone can make breathing easier during asthma problems, calm painful or swollen joints, soothe irritated skin, and reduce immune-related inflammation in other parts of the body. It is a powerful medicine, so doctors usually use it for the shortest time that still gives benefit. (MedlinePlus)

Prednisolone can be very helpful, but it is not a harmless medicine. Common side effects can include trouble sleeping, mood changes, increased appetite, weight gain, indigestion, acne, and thin or fragile skin. With longer use, it can raise the risk of infections, weak bones, diabetes that is harder to control, cataracts, glaucoma, and slower growth in children and teenagers. (nhs.uk)

Another important point is that prednisolone should not be stopped suddenly, especially after taking it for more than a few weeks or at higher doses. Stopping too fast can cause withdrawal symptoms such as severe tiredness, weakness, body aches, and joint pain, and the original health problem may flare up again. Doctors usually lower the dose gradually when it is time to stop. (nhs.uk)

In simple terms, prednisolone is a strong anti-inflammatory medicine that can bring real relief when the immune system is causing too much inflammation. Its biggest benefit is control: it can reduce pain, swelling, redness, and flare-ups, helping the body recover or stay stable while the underlying condition is treated. (MedlinePlus)

Prednisolone works by acting like cortisol, a natural hormone made by the adrenal glands. Cortisol helps regulate inflammation, stress responses, and immune activity. When the body is producing too much inflammation, prednisolone slows that process down. This is why it can work so quickly for many inflammatory and autoimmune conditions.

The medicine comes in several forms, including tablets, liquid solutions, eye drops, and injections. Doctors choose the form depending on the condition being treated. Eye drops may be used for eye inflammation, while tablets are more common for asthma attacks, allergic reactions, or autoimmune diseases affecting the whole body.

Prednisolone is often used as a short-term treatment during flare-ups, but some people with severe chronic illnesses may need it for longer periods. In those cases, doctors usually try to keep the dose as low as possible to reduce the risk of side effects.

People taking prednisolone for longer periods are sometimes advised to protect their bones because steroids can reduce bone strength over time. Doctors may recommend calcium, vitamin D, exercise, or other treatments to lower the risk of osteoporosis. Regular monitoring may also include blood pressure checks, blood sugar testing, and eye exams.

The medicine can also affect the immune system in ways that make infections easier to catch or harder to notice early. Fever and inflammation are part of the body’s normal defense system, and prednisolone can suppress those warning signs. Because of that, people taking higher doses are often told to contact a doctor if they develop signs of infection.

Prednisolone may interact with other medicines, including anti-inflammatory painkillers, blood thinners, diabetes medicines, and some vaccines. Alcohol can also increase the risk of stomach irritation or ulcers when combined with steroids. Doctors and pharmacists usually review a person’s medications carefully before treatment begins.

Although prednisolone can cause side effects, it is also considered one of the most important medicines in modern medicine because it can prevent serious complications from uncontrolled inflammation. In emergency situations, such as severe allergic reactions or dangerous asthma flare-ups, it can be life-saving.

Many people worry when they hear the word “steroid,” but corticosteroids like prednisolone are medical treatments designed to control harmful inflammation. When used carefully and under medical supervision, prednisolone can greatly improve comfort, function, and quality of life for people dealing with painful or severe inflammatory conditions.

What Makes Prednisolone Different From Other Corticosteroids?

Prednisolone is one of several medicines in the corticosteroid family, but it has a few features that make it different from other steroid drugs. The main differences involve how strong it is, how long it lasts in the body, how it is processed by the liver, and what kinds of conditions it is most often used to treat.

One important difference is that prednisolone is already in its active form. A closely related medicine called prednisone must first be converted by the liver into prednisolone before it becomes fully active. Because of this, prednisolone is often preferred for people who have liver problems or reduced liver function. In those cases, the body may not convert prednisone efficiently.

Prednisolone is considered a medium-strength corticosteroid. It is stronger than hydrocortisone, which is closer to the body’s natural cortisol hormone, but not as powerful as dexamethasone or betamethasone. This middle range makes prednisolone useful for many common inflammatory and autoimmune conditions because it offers strong anti-inflammatory effects without being among the most extreme steroids.

Another difference is how long the effects last. Prednisolone is classified as an intermediate-acting corticosteroid. Its effects usually last longer than hydrocortisone but not as long as dexamethasone. This balance allows doctors to control inflammation effectively while sometimes reducing the risk of prolonged suppression of the body’s natural hormone production.

Prednisolone also has moderate mineralocorticoid activity. That means it can affect salt and water balance in the body to some degree, potentially causing fluid retention or increased blood pressure. Other corticosteroids differ in this area. For example, dexamethasone has very little mineralocorticoid effect, while fludrocortisone has very strong effects on salt retention and is mainly used for hormone replacement rather than inflammation control.

The drug is widely used because it comes in many forms, including tablets, liquid solutions, eye drops, and injections. Prednisolone eye drops are especially common for treating eye inflammation after surgery or infection. Some other corticosteroids are not used as often in ophthalmology or may be formulated differently.

Doctors also choose corticosteroids based on how deeply they suppress the immune system. Prednisolone provides strong immune suppression, but some steroids such as dexamethasone can be even more potent at lower doses. This is why dexamethasone is sometimes preferred in situations involving severe brain swelling, certain cancers, or critical illness.

Side effects can vary slightly between corticosteroids because of differences in potency and duration. Longer-acting steroids may suppress the adrenal glands more strongly, while steroids with higher mineralocorticoid activity may cause more swelling or fluid retention. Prednisolone is often seen as a balance between effectiveness and manageable duration, which is one reason it is commonly prescribed around the world.

In simple terms, prednisolone stands out because it is already active in the body, has medium strength, lasts a moderate amount of time, and works well for a wide variety of inflammatory and autoimmune diseases. Those characteristics make it one of the most widely used corticosteroids in modern medicine.

(Source : ChatGPT)

In the middle of the twentieth century, doctors explored hormone treatments for various conditions linked to aging. One area of interest was senile pruritus and senile eczema, terms used at the time for intense itching and skin inflammation that often affected older people. Researchers noticed that these problems sometimes appeared alongside declining hormone levels, particularly in men. This led to small experiments with testosterone as a possible remedy.

A notable report came in 1945 from doctors William L. Dobes, Jack Jones, and Andrew G. Franks at Emory University. They published their findings in The Journal of Clinical Endocrinology & Metabolism. The team worked with ten patients who had senile pruritus, a condition marked by severe, widespread itching and sometimes skin changes resembling eczema. The patients received testosterone propionate through injections, local skin applications, and oral methyl testosterone.

According to the doctors, the treatment brought noticeable relief for many in the group. Itching decreased and skin symptoms improved in a good number of cases, especially when the issues seemed tied to age-related hormone decline. One example mentioned involved a patient whose pruritus and dermatitis came under control with testosterone after vitamins had not helped. The results were presented as promising for this specific type of age-related skin complaint.

These early observations fit with the idea that testosterone can influence the immune system. Modern understanding shows that testosterone tends to suppress Th2 immune responses, the type often overactive in atopic eczema and allergic skin conditions. By calming this pathway, the hormone could in theory reduce inflammation and itching. However, the 1940s work was not a large or tightly controlled clinical trial by today's standards. It involved only a handful of patients, lacked placebo comparisons, and focused mainly on older adults with senile forms of skin trouble rather than common atopic eczema seen in children or younger adults.

Later medical research has not turned testosterone into a standard treatment for eczema. Some studies have looked at hormone levels in people with atopic dermatitis and explored how testosterone might affect skin barrier function or inflammation, but results remain mixed. While it may help certain inflammatory aspects, there are also concerns that androgens can sometimes affect skin thickness or oil production in ways that are not always beneficial. No large-scale modern trials have established testosterone as a safe or effective option for routine eczema care.

The historical use of testosterone for senile pruritus and eczema reflects an era when doctors were just beginning to connect hormones with skin health and aging. Those small studies from the 1940s reported positive outcomes in relieving symptoms for many participants, yet they stayed limited in scope. Today, eczema management relies on moisturizers, topical steroids, newer anti-inflammatory creams, and other targeted therapies. The old experiments with testosterone serve mainly as an interesting footnote in medical history, highlighting how hormone balance can play a role in skin conditions.

(Source : Grok)

The Male Hormonal Shield: Testosterone’s Role in Dampening Allergic Inflammation

Sex steroid hormones have a profound influence on the immune system, and the relationship between testosterone and the arm of adaptive immunity governed by T helper 2 (Th2) cells is a particularly clear example of this regulation. Far from simply being a reproductive chemical, testosterone acts as a general suppressor of the immune system, and its effects are especially potent against the type of inflammation driven by Th2 cells. This interaction is a key biological reason why, after puberty, many allergic and Th2-dominated conditions such as asthma become significantly more common and severe in females than in males.

The primary effect of testosterone on a Th2-driven response is one of powerful suppression. The hormone works to actively dampen the entire inflammatory cascade. In animal models of allergic airway inflammation, a classic Th2-mediated disease, the presence of testosterone leads to a direct decrease in the accumulation of immune cells like eosinophils and neutrophils in the lungs. It also reduces the production of IgE antibodies and lessens airway hyperresponsiveness, the tendency of the airways to constrict too easily. Underlying these whole-body responses, testosterone decreases the number of Th2 cells in the lung that are actively producing the signature type 2 cytokine, IL-13, and reduces the production of other key Th2 cytokines such as IL-4 and IL-5. This suppressive effect is not limited to adaptive immunity; testosterone also acts on the innate arm of the immune system by potently inhibiting the proliferation and function of group 2 innate lymphoid cells (ILC2s), an early source of the same type 2 cytokines that shape the subsequent Th2 response.

The mechanism behind this suppression is multi-layered, involving direct molecular signaling and indirect cellular crosstalk. The most definitive pathway occurs when testosterone, or its more potent metabolite dihydrotestosterone (DHT), binds directly to the androgen receptor inside a naive T cell that is destined to become a Th2 cell. This hormone-receptor complex then moves to the cell’s nucleus and acts as a transcription factor, directly turning on the gene that encodes a protein called dual-specificity phosphatase 2 (DUSP-2). DUSP-2 is a negative regulator of the p38 MAP kinase signaling pathway, which is critical for the optimal production of Th2 cytokines. By boosting DUSP-2 levels, testosterone undermines the cell’s molecular machinery, preventing it from producing large amounts of the characteristic Th2 proteins. This direct signaling route is so central that in experiments where the androgen receptor is genetically deleted only from T cells, androgen treatment can no longer suppress Th2 cytokine production, and the animals develop a much more severe form of allergic inflammation.

In a parallel mechanism, testosterone also influences the Th2 response indirectly by first acting on other cell types. For instance, androgen signaling within the same T cell population can also suppress the development of Th17 cells. Th17 cells are not Th2 cells, but they produce IL-17A, a cytokine that is often elevated alongside Th2 cytokines in severe asthma and can exacerbate tissue inflammation. By suppressing the Th17 pathway, testosterone helps restructure the overall inflammatory environment into a less aggressive state. Furthermore, a crucial indirect path involves IL-4, the master cytokine that drives Th2 cell differentiation. Testosterone signaling through the androgen receptor has been shown to suppress the initial production of IL-4 from innate sources during an allergic reaction, which in turn leads to a secondary decrease in the number of IL-13-producing Th2 cells in the affected tissue. In this way, testosterone can tamp down the Th2 response without the androgen receptor ever needing to be activated inside the Th2 cell itself.

The clinical relevance of this androgen-Th2 interaction is most vividly illustrated by the sex disparity in diseases like asthma. Before puberty, the prevalence of asthma is higher in boys than girls, but this ratio reverses dramatically after adolescence, when adult women become about twice as likely to have asthma as men. This switch correlates with the rise in testosterone levels in males, which provides a protective effect against the Th2/ILC2-driven allergic inflammation in the lungs. In contrast, female sex hormones like estrogen tend to enhance Th2 responses. Therefore, testosterone is not just a bystander in Th2 immunity but a central regulator whose molecular actions—primarily the upregulation of DUSP-2 at the genomic level and the broader suppression of cytokine networks—explain why the male immune system is often biased away from developing potent and potentially harmful type 2 inflammatory responses.

How Testosterone Silences the Early Alarm: Epithelial Cells, Tregs, and the Th2 Axis

There are a few additional layers to this interaction that are worth noting, as they help to complete the picture of how testosterone shapes Th2-driven inflammation in real-world biology.

A significant part of the story involves the very earliest triggers of a type 2 immune response. The epithelial cells that line the airways, skin, and gut are the first to encounter allergens and parasites. When damaged or irritated, these cells release alarmin cytokines, particularly IL-33, TSLP, and IL-25, which act as a wake-up call to the immune system by activating ILC2s and setting the stage for a robust Th2 response. Testosterone and DHT signaling through the androgen receptor have been shown to suppress the release of these alarmins from airway epithelial cells. This means that before a Th2 cell even gets involved, testosterone is already working at the barrier surface to raise the threshold for initiating the entire allergic inflammatory cascade. By reducing the IL-33 that normally fuels ILC2s, testosterone indirectly starves the developmental path that leads to a dominant Th2 response.

Another nuance concerns the balance of T cell subtypes beyond the straightforward suppression of Th2 cells. Androgen signaling can also tilt the immune system toward tolerance by influencing regulatory T cells (Tregs). In some contexts, testosterone promotes the function and stability of Tregs, the cells responsible for calming down immune reactions and preventing excessive inflammation. A more active Treg compartment naturally restrains the expansion and activity of Th2 cells in mucosal tissues. This effect complements the direct DUSP-2 mechanism: the hormone not only makes it harder for a developing Th2 cell to produce its cytokines, but it simultaneously strengthens the suppressive network that keeps that cell in check.

The clinical picture extends beyond asthma. A condition that powerfully illustrates the immune consequences of removing testosterone’s influence is androgen deprivation therapy, a common treatment for prostate cancer. Men receiving these treatments, which drastically lower testosterone levels, experience a notable increase in Th2-related conditions such as allergic rhinitis and new-onset asthma. Their immune profiles shift toward higher levels of IgE and more pronounced eosinophilic inflammation. This human experiment of nature confirms that even in adulthood, the continuous presence of testosterone actively suppresses the Th2 axis. Conversely, in transgender men receiving masculinizing hormone therapy, reductions in Th2 biomarkers and improvements in pre-existing allergic symptoms have been observed, though research in this area is still growing.

Finally, it is important to remember that while testosterone broadly suppresses Th2 responses, its influence is part of a larger hormonal network. The final outcome of an immune challenge depends on the balance between testosterone and other hormones like progesterone and estradiol, as well as on local tissue concentrations of aromatase, the enzyme that converts testosterone to estradiol. This local conversion can create microenvironments where androgenic and estrogenic signals compete, adding a further layer of regulation that can differ from one organ to another. Nonetheless, the overarching theme remains consistent: testosterone, acting primarily through the androgen receptor to induce negative regulators like DUSP-2 and to dampen innate type 2 alarmins, serves as a critical brake on the development and severity of Th2-driven inflammation.

Testosterone: Shield Against Allergy, Gateway to Helminths

The discussion so far has focused on how testosterone suppresses Th2-driven inflammation in allergic disease, but there is another important dimension to this interaction that becomes clear when moving from allergy to infection. Th2 responses did not evolve to cause hay fever and asthma; they evolved to defend the body against large multicellular parasites, particularly helminth worms. In this context, testosterone’s suppressive effect on Th2 immunity represents a genuine biological trade-off, providing protection from allergic pathology while simultaneously increasing vulnerability to parasitic disease.

Across many mammalian species and in human populations, males consistently carry heavier burdens of intestinal worms and other helminths compared to females. This pattern is directly linked to the immunosuppressive action of androgens on the Th2 axis that would otherwise be responsible for expelling the parasites. In rodent models, castration of males leads to enhanced Th2 responses and more rapid worm clearance, while testosterone replacement restores susceptibility. The very same mechanisms that keep asthma in check, such as the reduction of IL-13, IL-4, and IL-5 production and the dampening of ILC2 activation, also impair the coordinated immune attack needed to expel worms from the gut or tissues. The testosterone-driven induction of molecules like DUSP-2 inside T cells, which serves as a brake on type 2 cytokine production, operates regardless of whether the antigen triggering the Th2 response is a harmless pollen grain or a life-threatening parasite.

This trade-off has real-world consequences. In regions where helminth infections are endemic, men often exhibit higher worm counts and a slower rate of spontaneous cure than women. This sex difference is most pronounced after puberty, exactly when testosterone levels diverge, and it fades again later in life as testosterone declines. So the effect of testosterone on Th2 biology is not simply a one-sided immunological handicap but a reshaping of the immune system that prioritizes resistance to certain classes of pathogens, such as intracellular bacteria and viruses driven by Th1 responses, at the expense of optimal defense against multicellular parasites. The Th2 suppression that spares males from many allergic conditions is the same force that can leave them more open to parasitic invasion, a classic evolutionary balance between protection and susceptibility.

(Source : DeepSeek)

Testosterone is a hormone that plays many important roles in the body, from driving physical development during puberty to maintaining muscle and bone strength throughout life. Despite its association with building and strengthening certain tissues, testosterone can have a very different effect on the skin, actually making it weaker over time. This may sound contradictory, but the process comes down to how the hormone interacts with the deep structural layers that give skin its resilience.

The skin’s strength and plumpness depend heavily on a meshwork of proteins, chiefly collagen and elastin, along with water-attracting molecules like hyaluronic acid. Collagen provides a sturdy scaffold, elastin allows the skin to stretch and snap back, and hyaluronic acid keeps everything hydrated and cushioned. When this support system is compromised, the skin becomes thinner, less elastic, and more fragile. Testosterone can interfere with all three of these critical components.

Deep within the dermis, the skin’s middle layer, special cells called fibroblasts are responsible for producing new collagen and elastin. These fibroblasts have docking stations, known as androgen receptors, that allow testosterone and related hormones to attach and send signals. When testosterone levels are high, the signals can dial down the fibroblasts’ activity. The cells begin to manufacture less procollagen, the raw material that gets woven into mature collagen fibers. At the same time, the hormone can ramp up the production of enzymes called matrix metalloproteinases, whose job is to break down existing collagen and elastin. The net result is a slower build rate and a faster demolition rate, leaving the skin’s scaffolding increasingly sparse and disorganized.

The impact does not stop with protein fibers. Testosterone also influences the skin’s water-holding capacity. Hyaluronic acid, which binds moisture and gives skin its bounce, is partly regulated by hormonal signals. Under the influence of higher testosterone activity, the skin may retain less hyaluronic acid, leading to a loss of hydration and volume. A dehydrated, less padded dermis is naturally more prone to creasing and damage.

There is a notable difference in how male and female skin typically age, and this difference highlights testosterone’s weakening effect. Before menopause, women’s higher estrogen levels help stimulate collagen production and maintain skin thickness. Men’s skin, which is exposed to sustained testosterone throughout adulthood, gradually becomes thinner and loses collagen at a steady rate. In fact, by middle age, a man’s dermis is often significantly thinner than a woman’s of the same age, and this thinner skin is more susceptible to cuts, tears, and wrinkles. Similar patterns can be seen when people undergo hormone therapy that raises testosterone levels, with some noticing that their skin becomes less plump and more fragile.

Beyond direct structural changes, testosterone stimulates the sebaceous glands to produce more oil. While oil itself is not inherently weakening, an overproduction can alter the skin’s barrier function and lead to chronic inflammation through conditions like acne. Persistent low-grade inflammation can further degrade collagen and elastin over time, adding another subtle layer of damage to the skin’s framework.

The weakening effect is not an all-or-nothing response. It depends on how much testosterone is present, how sensitive an individual’s androgen receptors are, and what other hormones are in the mix. Still, the underlying biology is clear. Testosterone has the capacity to thin the skin by slowing collagen production, speeding up its breakdown, and reducing the natural moisturizing factors that keep the tissue supple and strong. This dual action, working beneath the surface over months and years, explains why the hormone that strengthens so many other parts of the body can quietly undermine the structural integrity of the skin.

There is more to the picture, particularly when looking deeper at how testosterone is processed by the skin itself and how it affects layers beyond the dermis. This adds important context about why the weakening effect can vary so much from person to person.

The skin is not a passive target for testosterone floating in the bloodstream. It contains an enzyme called five-alpha reductase that converts testosterone into a much more potent androgen called dihydrotestosterone, or DHT. DHT binds to the same androgen receptors on fibroblasts but with far greater strength and for a longer duration, amplifying the signal that slows collagen production and ramps up the activity of collagen-degrading enzymes. The level of this enzyme in an individual’s skin dictates how intensely the hormonal message is felt. Someone with highly active five-alpha reductase in their dermal cells may experience more pronounced thinning even with normal circulating testosterone levels. This local hormone processing means the weakening of skin is not simply a matter of how much testosterone the body makes but also of how the skin itself transforms it.

The influence of testosterone also extends upward into the epidermis, the outermost living layer, and downward into the fat layer that cushions the skin. In the epidermis, androgens can subtly reduce the rate of cell turnover and may lead to a slightly thinner, less robust protective barrier. A thinner epidermis is more easily breached by irritants and loses water more readily, which compounds the dryness already set in motion by the loss of hyaluronic acid deeper down. Beneath the dermis, in the subcutaneous fat, testosterone tends to reduce the size and number of fat cells over time. This layer of fat acts as a natural shock absorber and provides structural fullness. When it shrinks, the skin above it loses some of its underlying support, becoming more prone to wrinkling, sagging, and mechanical injury because there is less padding to buffer everyday bumps and pressure.

Another aspect worth understanding is the indirect effect testosterone exerts through the balance of other hormones. A portion of the body’s testosterone is normally converted into estradiol, a form of estrogen, via an enzyme called aromatase that is also present in the skin. Estrogen is a strong friend to the skin, promoting fibroblast activity, collagen synthesis, and hydration. When testosterone levels are high but the efficiency of aromatase is low, the skin loses this protective conversion and the weakening effect of androgens goes largely unopposed. This explains why, for example, during andropause when testosterone and its conversion to estrogen both decline, skin aging can accelerate for different hormonal reasons, while in younger individuals with high testosterone and low aromatase activity, the skin might still thin prematurely. The net condition of the skin often reflects the ratio of androgen activity to estrogen activity within the tissue rather than the absolute level of testosterone alone.

Finally, the structural weakening also becomes visible in how the skin repairs itself after injury. Testosterone has been shown to dampen the early inflammatory phase of wound healing and slow the migration of keratinocytes needed to close a wound. Combined with a leaner collagen mesh and a thinner epidermis, this means that skin under a strong androgenic influence not only sustains damage more easily but also rebuilds itself more slowly, lengthening the time that the area remains vulnerable. This healing delay is a practical consequence of the same underlying mechanisms that cause gradual thinning over the years.

(Source : DeepSeek)

Often considered a female hormone, estrogen is actually present and essential in men as well. The male body produces estrogen throughout life, though in much smaller amounts than women of reproductive age. This might seem surprising, but the explanation lies in how hormones are made and what they do.

The primary male sex hormone is testosterone, which is produced mainly in the testes. A portion of this testosterone, however, does not stay in its original form. An enzyme called aromatase, found in various tissues like fat, brain, skin, bone and blood vessels, converts some testosterone into estradiol, the most potent type of estrogen. So estrogen in men is not a separate hormone imported from elsewhere; it is a natural byproduct of testosterone metabolism. This conversion is a normal, ongoing process that keeps a delicate balance between the two hormones.

The presence of estrogen in men serves several important purposes that go far beyond reproduction. One of the most vital roles is maintaining bone density. Estrogen helps signal the bones to preserve their strength and mineral content. Without enough estrogen, bones become fragile and prone to fractures, a condition known as osteoporosis. In fact, research has shown that estrogen may be even more critical than testosterone for protecting the male skeleton over a lifetime.

The brain also relies on estrogen. In regions that govern memory, mood and cognitive function, local aromatase activity supplies neurons with the estrogen they need. This hormone supports the health of brain cells, influences the formation of memories and helps regulate emotional well-being. When estrogen levels are too low, men can experience irritability, depression or difficulty concentrating.

Another key area is the cardiovascular system. Estrogen contributes to keeping blood vessels flexible and healthy. It plays a part in managing cholesterol levels and has antioxidant properties that protect the delicate lining of arteries. As a result, the right amount of estrogen helps reduce the risk of heart disease. Strikingly, metabolic health is also tied to this hormone. Estrogen affects how the body handles insulin, stores fat and burns energy. Men with very low estrogen levels, sometimes due to rare genetic conditions that block aromatase, tend to accumulate visceral fat and develop insulin resistance, showing just how necessary a proper estrogen balance is for metabolism.

Even in the realm of male sexual function, estrogen has a hand. While testosterone drives libido and erectile function in a direct way, estrogen helps modulate desire and supports certain aspects of sperm maturation. For instance, within the epididymis, a duct behind each testicle, estradiol assists in reabsorbing fluid, which concentrates and preserves sperm. The production of healthy sperm depends on a fine-tuned hormonal environment where estrogen is not absent but present in carefully controlled amounts.

Of course, the balance matters. Excessive estrogen in men, which can occur with obesity, aging or certain medications, may lead to breast tissue growth, reduced muscle mass or a lowered sex drive. Conversely, too little estrogen, as can happen with aromatase inhibitor use or some medical conditions, leads to bone loss, hot flashes, fatigue and sexual dysfunction. The body works hard to keep both testosterone and estrogen within ideal ranges, converting just enough to meet its needs without overshooting.

In plain terms, men have estrogen because it is literally built from testosterone and because their bodies require it to function. The hormone is not a marker of femininity but a fundamental chemical messenger that safeguards bones, brains, hearts and metabolism. Recognizing that estrogen is a normal part of male physiology helps clarify why hormonal health in men is not simply about having high testosterone, but about maintaining a harmonious balance between multiple hormones that all play their part.

A few additional points can deepen the picture. One interesting angle is the evolutionary history of estrogen receptors. These receptor proteins are ancient and appear in all vertebrates. The body's ability to respond to estrogen was established long before distinct male and female patterns diverged, so both sexes inherited the same basic signaling toolkit.

Another area worth noting is the skin. Estrogen supports collagen production and helps retain moisture, which keeps skin supple and aids in wound healing. In men, the steady conversion of testosterone into estradiol contributes silently to skin integrity over time.

The immune system also feels the influence. Estrogen modulates inflammatory responses and the activity of certain immune cells. This may partly explain why men and women respond differently to infections and autoimmune conditions, though the full picture is complex.

There is also a noteworthy clinical angle. When researchers study rare individuals who cannot produce aromatase or who have defective estrogen receptors, they see in sharp relief what happens without this hormone. Such men grow very tall because their growth plates fail to close properly, they develop severe osteoporosis by early adulthood, and they often struggle with metabolic issues like fatty liver and insulin resistance. These cases confirm that estrogen is not a supporting actor but a leading requirement for normal male development and health.

Finally, the pattern of hormonal change with age merits a mention. As men get older, testosterone levels often decline gradually, which reduces the raw material available for conversion to estradiol. The resulting dip in estrogen can contribute to some of the familiar changes of aging, including thinning bones and a slower metabolism, even if the drop is nowhere near as sudden as menopause. This quiet shift underscores how male health continues to depend on the steady, lifelong partnership between testosterone and its estrogenic derivatives.

The conversation around estrogen in men often overlooks a few subtler but telling details. One such detail involves the liver and its production of a carrier protein called sex hormone-binding globulin. The liver is sensitive to estrogen, and when estradiol levels rise, the liver responds by releasing more of this binding protein. This protein attaches to circulating testosterone and estrogen, temporarily holding them in reserve. Only the unbound portion of each hormone is active, so estrogen indirectly helps determine how much free testosterone is available. This creates a self-regulating loop that keeps the hormonal environment stable.

Another layer is the local, on-demand nature of estrogen production. The aromatase enzyme is not confined to one organ; it is distributed throughout tissues like bone, brain, fat and blood vessel walls. This means that a cell in a particular tissue can take up testosterone from the bloodstream and convert it to estrogen right at the point of need. The resulting estrogen often acts within that same tissue or its immediate surroundings before being inactivated, so the body can target its effects without raising hormone levels everywhere. In bone, for instance, local estrogen activity is essential for slowing the cells that break down bone tissue, providing site-specific maintenance that circulating levels alone could not achieve with such precision.

A striking developmental function appears at the end of puberty. In both sexes, the ultimate signal that tells the long bones to stop lengthening comes from estrogen. Inside the growth plates near the ends of bones, the enzyme aromatase converts some of the testosterone that surges during male adolescence into estradiol. This estradiol triggers a cascade that closes the growth plates, fusing the bone and setting final adult height. Without that estrogenic signal, a man would continue to grow taller well into adulthood, a phenomenon clearly observed in rare cases of aromatase deficiency.

From a clinical standpoint, appreciating that men rely on estrogen has practical consequences. Certain treatments, such as aromatase inhibitors used for hormone-sensitive conditions, can push estrogen levels too low. When that happens, the absence of estrogen's protective influence shows up as accelerated bone thinning, joint discomfort, fatigue and changes in cholesterol profiles. These outcomes underline that aiming for an optimum, not a complete elimination, is what preserves male health. The male body does not tolerate estrogen’s presence grudgingly; it builds it deliberately, uses it locally, and depends on it across a lifetime for a surprisingly wide range of tasks.

(Source : DeepSeek)

CBD and THC are two chemicals found in cannabis. When they are used together in a prescription medicine such as nabiximols, they have been studied most in people with multiple sclerosis-related spasticity, which is a type of muscle stiffness, tightness, and involuntary spasms caused by nerve damage. The best evidence is for that specific medical use, not for all kinds of spasms. In research reviews, oral cannabinoids and THC:CBD spray have shown a modest benefit for patient-reported spasticity symptoms, especially in multiple sclerosis. (CNIB)

The reason this combination may help is that the body already has its own cannabinoid system, called the endocannabinoid system. This system helps regulate how nerve cells talk to each other. THC partly activates CB1 and CB2 receptors, which are found mainly at nerve terminals. When these receptors are activated, they can reduce the release of neurotransmitters such as glutamate, which helps calm overactive nerve signaling. In plain terms, the medicine may quiet some of the nerve messages that keep muscles too “switched on.” (Medicines.org.uk)

That calming effect matters because many spasms are driven by the nervous system, not by the muscle itself. In conditions like multiple sclerosis, damaged nerves can send abnormal signals to muscles, making them stiff, tight, or prone to sudden contractions. By reducing excessive signaling in the brain and spinal cord, THC-containing medicines may lower muscle tone and reduce the feeling of stiffness. Animal and human evidence supports this idea, but the effect is usually not dramatic. (Medicines.org.uk)

CBD’s role is less straightforward. CBD does not act like THC in the same direct way, and the exact mechanism for spasm relief is still not fully clear. In combination products, CBD may help balance some of THC’s unwanted effects, and studies suggest it can influence how THC behaves in the body and how strongly its psychoactive effects are felt. That said, the main spasm-relieving action is generally thought to come from THC-driven cannabinoid receptor activity, with CBD acting more as a partner than the main driver. (PMC)

The strongest clinical evidence is for prescribed products like Sativex, which contains THC and CBD in roughly equal amounts and is used in some countries for moderate to severe MS-related spasticity when other treatments have not helped enough. Official product information says it is intended as add-on treatment, and patients are usually assessed during an initial trial to see whether they improve. Reviews also note that the average benefit is modest, and not everyone responds. (Medicines.org.uk)

That modest effect is important. Research found improvements in patient-reported spasticity, but the change was often small, and benefits were not always seen on clinician-measured spasticity scales. In some studies, a meaningful improvement appeared only in a subset of patients, which is why many prescribing rules use a trial period and stop treatment if there is no clear response. (CNIB)

Side effects are a real part of the picture. Common problems include dizziness, drowsiness, fatigue, dry mouth, changes in taste, and thinking or memory issues. Psychiatric effects can also occur, especially in people with a history of psychosis. Because THC can affect alertness and coordination, these medicines may also impair driving or the use of machinery. (MS Trust)

So, CBD and THC together can help some people with spasms because they can dampen overactive nerve signaling through the cannabinoid system. The effect is most established for multiple sclerosis-related spasticity, and even there it is usually partial rather than complete. The combination is best understood as a symptom treatment that may reduce stiffness and spasms in selected patients, not as a universal cure for muscle spasms of every cause. (CNIB)

A few important points add useful context and help keep expectations realistic.

First, the type of spasm matters a lot. The evidence for THC and CBD is mainly for neurological spasticity, especially in conditions like multiple sclerosis. That is different from common muscle cramps after exercise, electrolyte imbalance, or fatigue. Those everyday cramps are usually driven by muscle metabolism or dehydration rather than nerve signaling, so cannabinoids are much less likely to help in a meaningful way.

Another useful detail is how these compounds are used clinically. The best-studied form is not smoked or homemade cannabis, but a standardized medicine called nabiximols (often known as Sativex). It delivers a controlled ratio of THC to CBD, which matters because too much THC increases side effects without necessarily improving spasm control. This highlights a key limitation: results from medical formulations do not always translate to over-the-counter CBD products or recreational cannabis.

It is also worth noting that tolerance can develop over time. The body’s cannabinoid receptors may become less responsive with repeated exposure, which means the effect on spasms can plateau or diminish. This is one reason why some patients report that the benefit feels stronger at the beginning of treatment.

Interactions with other medications are another practical concern. Both THC and CBD can affect liver enzymes that process drugs, meaning they can increase or decrease the levels of other treatments in the body. This is particularly relevant for people already taking medications for neurological conditions, pain, or sleep.

There is also a distinction between subjective relief and objective change. Many studies show that patients feel less stiffness or discomfort, even when measurable muscle tone does not change much. This suggests part of the benefit may come from altered perception of discomfort or improved sleep, not just direct muscle relaxation.

Finally, long-term safety is still being studied. Short-term use is relatively well understood, but questions remain about cognitive effects, dependence risk, and mental health impact with prolonged THC exposure, especially at higher doses.

Taken together, THC and CBD can play a role in managing certain types of spasms, but their usefulness depends heavily on the underlying cause, the formulation used, and individual response.

(Source : ChatGPT)

In addition to the core mechanisms already described, the practical future of nanogold as an anti-inflammatory and antioxidant agent depends significantly on how the particles are designed and how the body ultimately handles them. The size of the nanoparticle is a critical factor. Particles that are too large cannot easily enter cells, while very small particles under six nanometers may be rapidly cleared from the bloodstream by the kidneys. The sweet spot for cellular uptake and longer circulation often falls in the range of ten to fifty nanometers, though this can shift based on the surface coating.

The shape of the particle also dictates its biological fate. Nanospheres, nanorods, nanostars, and nanocages all interact with cells differently. Nanostars, with their many sharp tips, can concentrate surface electrons at their points, creating local hot spots of chemical reactivity that can enhance antioxidant enzyme-like activity. However, these same sharp structures can sometimes mechanically puncture cell membranes, a useful trait for destroying harmful cells but a concern for healthy tissue. Nanorods and nanocages have been explored extensively for their ability to absorb near-infrared light, allowing them to combine anti-inflammatory drug delivery with mild heat therapy to increase blood flow and tissue repair.

The surface coating is perhaps the most complex variable. Pristine, uncoated gold nanoparticles are not stable in the salty environment of biological fluids and will clump together. To prevent this, they are almost always decorated with a layer of stabilizing molecules. These can be simple polymers like polyethylene glycol, which creates a stealth effect that hides the particle from the immune system and extends its circulation time. Alternatively, they can be functionalized with natural antioxidants such as polyphenols from green tea, curcumin from turmeric, or resveratrol from grapes. When these molecules are packed densely on the particle surface, their local concentration is massively increased, and the gold core can help regenerate them after they have neutralized a free radical, effectively creating a reusable antioxidant platform. Other coatings, like chitosan from shellfish shells or hyaluronic acid from joint fluid, can add their own wound-healing and anti-inflammatory properties while also targeting particles to specific tissue types.

There is also a growing awareness of the subtle role nanogold can play in clearing out damaged cellular components. Chronic inflammation and oxidative stress are often linked to the accumulation of malfunctioning mitochondria and misfolded proteins. Some studies suggest gold nanoparticles can gently stimulate a cellular housekeeping process called autophagy. By encouraging cells to recycle this internal debris, the particles may help restore normal function in tissues that are stuck in a state of low-grade inflammation, such as the lining of blood vessels in atherosclerosis or the neurons in Parkinson's disease models.

It is equally necessary to acknowledge the gaps and cautions in this field. While gold is chemically inert as a bulk metal, its immune reactivity at the nanoscale is a double-edged sword. Certain sizes and shapes can accumulate in the liver and spleen, where they may persist for months. Whether this long-term retention poses a risk of chronic low-level irritation or eventual clearance via slow dissolution remains a subject of ongoing research. The so-called protein corona, a thick layer of proteins that instantly coats the particle upon entering the blood, can completely mask the engineered surface and alter its targeting and anti-inflammatory capacity in unpredictable ways. These challenges explain why, despite a large body of preclinical evidence, translation to government-approved therapies has been slow. Advances are being made through the design of biodegradable ultra-small particles that can be filtered by the kidneys and through bio-inspired coatings that actively recruit anti-inflammatory proteins from the blood to form a beneficial corona. These emerging strategies aim to harness the fundamental antioxidant and anti-inflammatory chemistry of nanogold while making its behavior inside a living system more predictable and safe.

There is another dimension to the anti-inflammatory and antioxidant effects of nanogold that extends beyond the direct chemical neutralization of reactive molecules or the silencing of inflammatory switches inside macrophages. This involves the way nanogold communicates with the outermost barrier of the body when applied topically, and how it can influence the wider adaptive immune system, the branch of immunity that remembers past threats.

When formulated into gels, creams, or wound dressings, gold nanoparticles interact directly with the keratinocytes and fibroblasts found in the skin. These cells are not just structural; they are active participants in immune surveillance and wound healing. In a wound or an inflammatory skin condition, these cells release a barrage of chemokines and growth factors that call in inflammatory immune cells. The tiny size of nanogold allows it to slip through the outer layers of the skin, particularly if the barrier is already compromised, reaching these deeper cells. Once there, beyond simply scavenging reactive oxygen species, the particles can modulate the expression of growth factors like transforming growth factor-beta and vascular endothelial growth factor. This can shift the healing process away from a messy, overly aggressive inflammatory state toward a more orderly reconstruction of tissue. This partly explains why early studies in burn wounds and diabetic ulcers observed not only a reduction in redness and swelling but also an improvement in the quality of the healed skin, with better collagen alignment and less scarring.

The influence of nanogold also reaches the adaptive immune cells, the T and B lymphocytes, which can drive chronic inflammatory and autoimmune diseases. In experimental models of inflammatory arthritis, exposure to certain sizes of gold nanoparticles has been shown to increase the population of regulatory T cells, often called Tregs. These are the peacekeepers of the immune system, responsible for shutting down excessive immune responses and preventing the body from attacking its own tissues. By encouraging the formation of these Tregs, nanogold can help re-establish immune tolerance, calming inflammation from a higher level of command rather than just mopping up the inflammatory molecules that have already been released. This effect is being explored for conditions like rheumatoid arthritis and allergic airway inflammation, where a failure of Treg function allows chronic inflammation to persist.

Another area that has gained attention is the emergence of atomically precise gold nanoclusters, which are typically composed of only a handful of gold atoms, often between ten and a few hundred, protected by a shell of molecules. Unlike larger nanoparticles that exhibit metallic properties, these ultra-small clusters behave more like molecules with discrete energy levels. This gives them an exceptionally high catalytic efficiency for eliminating reactive oxygen species, sometimes outperforming the body’s own natural antioxidant enzymes by a wide margin. Their molecular-like structure can also lead to unexpected interactions, such as the ability to bind to specific DNA sequences or protein pockets with a level of precision that larger nanoparticles cannot achieve, opening up the possibility of blocking inflammatory signals at their source.

Despite these promising angles, the route of administration dictates a completely different biological journey. Inhaled nanogold, for example, encounters lung surfactant and alveolar macrophages, presenting a different safety profile and anti-inflammatory dynamic compared to intravenously injected particles that end up in the liver. Oral ingestion, as is common with unregulated colloidal gold supplements, introduces the particles to harsh stomach acid and the complex ecosystem of the gut microbiome. There is preliminary evidence that gold particles can alter the composition of gut bacteria, which itself modulates whole-body inflammation, but whether this is a beneficial shift or a subtle disruption is not well understood. This wide gap between the various routes of exposure and the well-orchestrated lab studies remains a central frontier. The ability to precisely engineer nanogold to travel through a specific compartment of the body, act on a specific cell type to reduce oxidative damage, and then safely degrade or exit the body without leaving behind an unintended legacy is the challenge that currently separates the compelling experimental mechanisms from the realities of accepted clinical practice.

(Source : DeepSeek)

Gold nanoparticles, often referred to as nanogold, are microscopic particles of gold that are thousands of times smaller than the width of a human hair. At this tiny scale, gold behaves very differently from the bulk metal found in jewelry, displaying new chemical and biological properties. Among the most researched of these properties are the ability to reduce oxidative stress and calm inflammation. The way nanogold accomplishes this is rooted in its surface chemistry, size, and ability to interact with the molecules and signals that drive these processes in the body.

Inflammation is the body’s natural defense response to injury, infection, or harmful stimuli. While short-term inflammation is protective, chronic inflammation can damage healthy tissue and contribute to many diseases. Nanogold appears to act on several key steps in the inflammatory cascade. One major pathway involves a protein complex called nuclear factor kappa B, or NF-κB. When cells are under stress, NF-κB moves into the cell nucleus and switches on genes that produce pro-inflammatory messengers like tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6. These messengers then recruit more immune cells and amplify inflammation. Studies in cell cultures and animal models have shown that gold nanoparticles can block the activation of NF-κB. By preventing this master switch from turning on, the particles reduce the release of the downstream inflammatory signals. Additionally, nanogold can inhibit enzymes such as cyclooxygenase-2 and inducible nitric oxide synthase, which are responsible for producing other inflammation-driving substances. Further down the signaling chain, certain enzymes known as mitogen-activated protein kinases, or MAPKs, are also dampened by nanogold. This multi-point interference helps shift the immune environment from a state of active attack to one of repair. In macrophages, the immune cells that orchestrate inflammation, exposure to nanogold can encourage a change from a pro-inflammatory M1 phenotype to an anti-inflammatory M2 phenotype. This M2 state is associated with the release of interleukin-10, a cytokine that actively resolves inflammation and promotes healing. There is also evidence that nanogold can reduce the assembly of a structure called the NLRP3 inflammasome, a sensor inside cells that triggers a potent inflammatory form of cell death and the release of inflammatory signals. By calming this sensor, the particles further tip the balance toward an anti-inflammatory state.

The anti-inflammatory effects of nanogold are closely linked to its ability to counteract oxidative stress. Oxidative stress occurs when there is an excess of reactive oxygen species and reactive nitrogen species, which are chemically unstable molecules that can damage DNA, proteins, and cell membranes. The body uses its own antioxidant enzymes, such as superoxide dismutase, catalase, and glutathione peroxidase, to keep these reactive molecules in check, but when the system is overwhelmed, harmful chain reactions occur, and inflammation often follows. Nanogold can mimic the activity of these natural antioxidant enzymes. Because of their extremely high surface area relative to their volume, gold nanoparticles provide a large number of atoms that can participate in chemical reactions. The surface atoms readily interact with reactive molecules like superoxide anions, hydrogen peroxide, and hydroxyl radicals, converting them into less harmful substances such as water and oxygen. This enzyme-like catalytic behavior effectively lowers the overall burden of free radicals. In addition to this direct scavenging, nanogold can boost the body’s internal antioxidant defenses. Through the activation of the Nrf2 pathway, a primary regulator of cellular resilience, gold nanoparticles prompt cells to increase their own production of protective enzymes and molecules like glutathione. The size, shape, and surface coating of the nanoparticles profoundly influence these activities. Smaller spherical particles with a high proportion of corner and edge atoms often display stronger catalytic efficiency. Moreover, the coating used to stabilize the particles can add another layer of protection or even provide mild antioxidant properties of its own.

Oxidative stress and inflammation fuel each other in a vicious cycle, and by disrupting both simultaneously, nanogold tackles the problem at its interconnected roots. When the particles neutralize reactive oxygen species, they remove a trigger that would otherwise activate NF-κB and the inflammasome. At the same time, by calming the inflammatory signaling pathways, they reduce the cellular production of more reactive species by enzymes like NADPH oxidase, which immune cells use as a weapon. This dual action has generated considerable interest for conditions in which oxidative and inflammatory damage go hand in hand, such as rheumatoid arthritis, neurodegenerative disorders, and chronic wounds. In experimental models of arthritis, for instance, injected nanogold has been observed to reduce joint swelling, lower the levels of inflammatory cytokines in the joint fluid, and decrease markers of cartilage breakdown.

It is important to emphasize that the vast majority of this evidence comes from laboratory experiments using cells and animal models, not from large-scale human clinical trials. The doses, routes of administration, and long-term safety remain active areas of investigation. The behavior of nanogold inside a living organism depends heavily on its specific design, including size, shape, surface charge, and the molecules attached to its surface. While the fundamental mechanisms of its antioxidant and anti-inflammatory action are well documented in a research setting, translating these findings into proven and approved medical treatments will require a deeper understanding of how different particles behave in the complex environment of the human body over time. Nonetheless, the ability of nanogold to reduce oxidative stress by mimicking natural enzymes and to calm inflammation by interrupting key signaling pathways like NF-κB makes it a compelling subject for the development of future therapies.

(Source : DeepSeek)

The shiny lustre of gold has fascinated people since ancient times. But using some ingenious chemistry to produce particles of gold so small that they are measured in billionths of a meter (nanometers), opens up a whole new world.

Though aesthetically pleasing, gold is scientifically quite boring. It is chemically inert, meaning it doesn’t easily react with other chemicals and remains shiny for long periods which is why it is prized in jewelry. But when it comes to tiny pieces of gold, only nanometers long, the science becomes far more interesting. These mini metal flecks of gold nanoparticles have potentially far-reaching applications.

The Big History of Nanotechnology

In 1669, German chemist Johann Kunckel made a remarkable discovery. Adding tin chloride and a solution of gold dissolved in “aqua regia” to molten glass resulted in a stunning ruby-red colour. He didn’t know it of course, but the red colour was due to particles of nanogold. Aqua regia is a mixture of hydrochloric and nitric acids and is one of the few reagents with which cold will react. The gold chloride that forms can be converted back to gold by reaction with tin chloride, but the gold now is in the form of nanoparticles that absorb all colours of light except for red which is reflected.

Modern nanotechnology began with the invention of the scanning tunnelling microscope in 1981. This was the first time scientists could ‘see’ on the nanoscale. An atom is about 10-10 meters, and a nanometer is 10-9 meters. This means that when we talk about ‘nanotechnology’ or ‘nanoparticles’, we refer to things made of a couple of thousand atoms. The scanning tunnelling microscope also made possible the manipulation of individual atoms, which allowed scientists to create nanoparticles.

Nanoparticles are different from their smaller or larger cousins because their size and shape directly affect their chemical properties. Imagine that the way you cut your bread changed the flavour; a diagonal slice gave you cinnamon bread, but a horizontal slice changed the same piece of bread into sourdough. This is similar to what is happening on the nanoscale! A sphere of gold has different properties than a cylinder of gold, which is different from a cube despite all being made of gold. One property that changes with the size and shape of a nanoparticle is colour. A long gold nanotube will reflect red light, but a shorter nanotube will reflect turquoise-blue light, as was finally explained by Richard Adolf Zsigmondy who was awarded the 1925 Nobel Prize in Chemistry for his work on colloids, tiny insoluble particles suspended in another substance.

Now we come to a truly exciting finding. A new type of cancer treatment uses gold nanoparticles' flexible properties to kill tumour cells! Cancer is a terrifying disease. Although there have been great advances in treatment, cancer is still Canada's leading cause of death. Normal, healthy cells replicate based on copies of a genetic code. In cancerous cells, there are mutations (or typos) in the genetic code, causing erroneous replication and abnormal growth. Once cancerous cells replicate enough, they form a tumour. Tumours generate blood vessels to get nutrients and hijack our immune system to protect themselves, all at the cost of our normal, healthy cells. Because tumours are so dangerous, cancer therapies focus on destroying tumour cells with minimal damage to healthy cells. This is where gold nanoparticles come into the picture.

Cancer photothermal therapy (PTT) is a minimally invasive treatment that uses nanoparticles to convert light energy into heat energy (hence the name photo-thermal!). First, gold nanoparticles are injected into the bloodstream. To help the nanoparticles find the tumour, scientists can attach special targeting ligands that act as ‘keys’ that only fit into a tumour cell’s ‘lock’. Once the gold nanoparticles find the tumour cells, the second stage of the therapy begins.

A specific type of light, called Near Infrared Radiation (NIR), is directed at the tumour. These light waves will travel through surrounding tissue and hit the gold nanoparticles, which are specially shaped to absorb this wavelength of light. Remember how we talked about different slices of bread - or shapes of nanoparticles - having different properties? Scientists experimented with different nanoparticle shapes and found that for PTT, gold nanorods, shaped like cylinders, or gold nanocages, shaped like hollow cubes, best absorb NIR.

The last stage of PTT is possible thanks to surface plasmon resonance. This fancy terminology refers to gold nanoparticle’s ability to turn the light waves from NIR into synchronized electron movement. The synchronized electron ‘wiggles’ generate thermal energy, or heat, which is then transferred to the nearby tumour cell. Gold nanoparticles can increase the temperature around a tumour to somewhere between 41 and 47 degrees Celsius – hot enough to seriously damage tumour cells. Gold nanoparticles are great candidates for PTT because they are especially good at converting light into thermal energy.

There is some cool science behind gold nanoparticle cancer-fighting powers, but cool science in the lab doesn’t necessarily transfer to effective treatment. One of the most complex steps in drug development is jumping from experiments in cell culture or animal models to demonstrating that a treatment actually works in patients. Gold nanoparticle PTT is still in this ‘jumping’ stage, and it’s potential is difficult to predict. An initial clinical trial in prostate cancer has shown promise and other clinical trials in lung and head and neck cancer are underway. There is some uncertainty about the long-term effects of gold nanoparticles, and some worry about serious side effects.

To be sure, gold nanoparticles have come a long way from producing ruby-glass and perhaps in the future may even make for a gold standard in cancer treatment.

(Source : McGill)

Peng Zhang is excited about gold, and you should be too. In particular, he's excited about nanogold, structures of a handful of atoms measuring only a few nanometers in diameter. Zhang, a researcher at Dalhousie University, and Canadian Light Source synchrotron user, has a unique understanding of the potential nanogolds have in biomedicine and beyond.

For one thing, gold is essentially non-toxic. Unlike other metals, people can and do eat it on chocolate, and as Zhang points out, "You can even drink gold, and you can even find certain alcohols with gold in them."
It's also incredibly stable. It doesn't rust, since its oxidized or rusted form is less stable than unadulterated gold. Decaying bridge joints and the green Lady Liberty speak to just how rare a stable metal is.
Combining those two properties in biomedicine means that you could use gold without worrying about the treatment losing its effectiveness or hurting the patient.

Zhang's team believes nanogold could be a good fit as a catalyzing agent, something that speeds up other reactions without getting used up itself. Due to the extremely small size of nanogolds, they were recently found to be efficient catalysts for converting toxic gases into nontoxic ones.

Plus, nanogold's incredible stability gives it an advantage over other metal-based catalysts, which tend to have shorter lifetimes.

In order to harness nanogold's potential, researchers have to make sense of its structures and behaviours, which are in many ways completely different from those of typical chunks of gold.

Which brings up another way in which gold is unique: you can't use the same techniques you would to study it as you would other common elements like carbon or nitrogen. Instead, researchers rely on X-ray based spectroscopy, specifically XAS (X-ray Absorption Spectroscopy) and XPS (X-ray Photoelectron Spectroscopy), techniques available on several CLS beamlines and its partner beamlines in the U.S.
Zhang has been using the CLS for his research since he was a student himself, under founding CLS researcher TK Sham. Since then, the facility has become a go-to for him both for the relationships he's built and the excellence of its available techniques.

"When we need low energy X-rays we always come to the CLS. The Canadian synchrotron is particularly good in low energy X-ray techniques," Zhang explained.

Using these synchrotron techniques, Zhang's research team is able to finely model the electronic structure of the nanoclusters, noting variations in structure and properties of the clusters caused by shifts of one or two atoms.

That such minuscule variations actually caused changes in the electronic behaviour of gold was something of a surprise. For one thing, researchers have only recently been able to reliably produce gold nanoclusters with specific numbers of atoms, making specific observations infuriatingly hard to come by.

For another, most nano tech applications would treat variations of a couple of atoms in a cluster as a negligible variance.

Not so for gold clusters with a few tens of atoms. A cluster of 36 gold atoms has a completely different structure than a cluster of 38 atoms, with vastly different electron densities, making each appropriate for different types of catalytic reactions.

"It was a very big surprise to us, and it's useful, because if you tailor the composition, you can very efficiently control the properties," Zhang said.

Only by harnessing new techniques to produce incredibly uniform samples of single-size gold clusters and observing their individual properties and structures was Zhang's lab able to start cataloguing the variety of properties of this nano wonder. In this regard, Zhang's collaborators, such as Rongchao Jin from Carnegie Mellon University, can achieve higher than 99% purity for the gold clusters.

As the team continues to explore how they can tailor and refine gold nano structures, they're also looking into ways to harness other noble metals in combination with gold. Silver and platinum, both valuable metals and with interesting medical and catalytic potential in their own right, could reveal new potential using the analytic techniques used by Zhang's team.

Next up, Zhang plans to look into gold and metal composites, to understand how these structures work. The team also remains committed to examining potential biomedical applications for their work, in collaboration with biomedical researchers from Dalhousie University and Halifax Infirmary Hospital.

(Source : Phys.org)